Clinical and Preclinical Evidence of the Skeletal and Vascular Adverse Health Effects of High Dietary Phosphorus

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Unknown venue

• Publication date

  2017-09-27

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.1201/9781315119533-11
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Phosphorus Additives and Albuminuria in Early Stages of CKD: A Randomized Controlled Trial.

  2017cited by this paper
• Direct inhibition of osteoblastic Wnt pathway by fibroblast growth factor 23 contributes to bone loss in chronic kidney disease.

  2016cited by this paper
• MicroRNAs 29b, 133b, and 211 Regulate Vascular Smooth Muscle Calcification Mediated by High Phosphorus.

  2016cited by this paper
• Differential expression and regulation of Klotho by paricalcitol in the kidney, parathyroid and aorta of uremic rats

  2015cited by this paper
• Anti‐Sclerostin Antibody Treatment in a Rat Model of Progressive Renal Osteodystrophy

  2015cited by this paper
• Phosphorus content of popular beverages.

  2015cited by this paper
• A 12-week, double-blind, placebo-controlled trial of ferric citrate for the treatment of iron deficiency anemia and reduction of serum phosphate in patients with CKD Stages 3-5.

  2015cited by this paper
• Fibroblast growth factor 23 accelerates phosphate-induced vascular calcification in the absence of Klotho deficiency.

  2014cited by this paper
• Dietary phosphorus intake and health1-3.

  2014cited by this paper
• Molecular interactions of FGF23 and PTH in phosphate regulation

  2014cited by this paper
• Vitamin D and risk of cause specific death: systematic review and meta-analysis of observational cohort and randomised intervention studies

  2014cited by this paper
• CKD-induced wingless/integration1 inhibitors and phosphorus cause the CKD-mineral and bone disorder.

  2014cited by this paper
• Association of 25-hydroxyvitamin D and parathyroid hormone with incident hypertension: MESA (Multi-Ethnic Study of Atherosclerosis).

  2014cited by this paper
• Effects of High Doses of Cholecalciferol in Normal Subjects: A Randomized Double-Blinded, Placebo-Controlled Trial

  2014cited by this paper
• High-phosphorus/zinc-free diet aggravates hypertension and cardiac dysfunction in a rat model of the metabolic syndrome.

  2014cited by this paper
• Contribution of food additives to sodium and phosphorus content of diets rich in processed foods.

  2014cited by this paper
• Phosphate overload directly induces systemic inflammation and malnutrition as well as vascular calcification in uremia.

  2014cited by this paper
• Who and what drove Walter Kempner? The rice diet revisited.

  2014cited by this paper
• The kidney is the principal organ mediating klotho effects.

  2014cited by this paper
• Vascular calcification is dependent on plasma levels of pyrophosphate

  2014cited by this paper
• High dietary phosphorus intake is associated with all-cause mortality: results from NHANES III.

  2014cited by this paper
• High phosphate diet increases arterial blood pressure via a parathyroid hormone mediated increase of renin

  2014cited by this paper
• Seven Dietary Minerals (Ca, P, Mg, Fe, Zn, Cu, and Mn) and Their Relationship with Blood Pressure and Blood Lipids in Healthy Adults with Self-Selected Diet

  2013cited by this paper
• A low fractional excretion of Phosphate/Fgf23 ratio is associated with severe abdominal Aortic calcification in stage 3 and 4 kidney disease patients

  2013cited by this paper
• Mechanistic insights into vascular calcification in CKD.

  2013cited by this paper
• FGF23 and Klotho in chronic kidney disease

  2013cited by this paper
• Effects of Phosphate Binder Therapy on Vascular Stiffness in Early-Stage Chronic Kidney Disease

  2013cited by this paper
• Effects of Dietary Phosphate on Adynamic Bone Disease in Rats with Chronic Kidney Disease – Role of Sclerostin?

  2013cited by this paper
• Public health impact of dietary phosphorus excess on bone and cardiovascular health in the general population.

  2013cited by this paper
• Effects of dietary phosphate restriction and phosphate binders on FGF23 levels in CKD.

  2013cited by this paper
• The prevalence of phosphorus-containing food additives in top-selling foods in grocery stores.

  2013cited by this paper
• Faculty of 1000 evaluation for Primary prevention of cardiovascular disease with a Mediterranean diet.

  2013cited by this paper
• Serum FGF23 and risk of cardiovascular events in relation to mineral metabolism and cardiovascular pathology.

  2013cited by this paper
• Cardiovascular risk factors in CKD associate with both ESRD and mortality.

  2013cited by this paper
• Expression of FGF23/KLOTHO system in human vascular tissue.

  2013cited by this paper
• Maternal and offspring pools of osteocalcin influence brain development and functions.

  2013cited by this paper
• Repression of osteocyte Wnt/β‐catenin signaling is an early event in the progression of renal osteodystrophy

  2012cited by this paper
• Dietary Phosphate Binding and Loading Alter Kidney Angiotensin-Converting Enzyme mRNA and Protein Content in 5/6 Nephrectomized Rats

  2012cited by this paper
• Effects of phosphate binders in moderate CKD.

  2012cited by this paper
• Vegetarian diets and blood pressure among white subjects: results from the Adventist Health Study-2 (AHS-2)

  2012cited by this paper
• Fibroblast growth factor-23 and death, heart failure, and cardiovascular events in community-living individuals: CHS (Cardiovascular Health Study).

  2012cited by this paper
• A systematic review and meta-analysis of elevated blood pressure and consumption of dairy foods

  2012cited by this paper
• Effect of dietary protein supplementation on blood pressure: a randomized, controlled trial.

  2011cited by this paper
• Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis.

  2011cited by this paper
• Vegetarian compared with meat dietary protein source and phosphorus homeostasis in chronic kidney disease.

  2011cited by this paper
• Arterial injury promotes medial chondrogenesis in Sm22 knockout mice.

  2011cited by this paper
• Fibroblast growth factor 23, cardiovascular disease risk factors, and phosphorus intake in the health professionals follow-up study.

  2011cited by this paper
• Parathyroid hormone, vitamin D, renal dysfunction, and cardiovascular disease: dependent or independent risk factors?

  2011cited by this paper
• Bone Gla Protein Increases HIF-1&agr;–Dependent Glucose Metabolism and Induces Cartilage and Vascular Calcification

  2011cited by this paper
• Klotho deficiency causes vascular calcification in chronic kidney disease.

  2011cited by this paper
• Vascular Calcification in Patients with Chronic Kidney Disease: Types, Clinical Impact and Pathogenesis

  2011cited by this paper
• Calcium Regulates Key Components of Vascular Smooth Muscle Cell–Derived Matrix Vesicles to Enhance Mineralization

  2011cited by this paper
• Treatment with pyrophosphate inhibits uremic vascular calcification.

  2011cited by this paper
• Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease.

  2011cited by this paper
• FGF‐23/Klotho signaling is not essential for the phosphaturic and anabolic functions of PTH

  2011cited by this paper
• FGF23 induces left ventricular hypertrophy.

  2011cited by this paper
• Calcium, phosphorus, PTH and death rates in a large sample of dialysis patients from Latin America. The CORES Study.

  2011cited by this paper
• The connections between vascular calcification and bone health.

  2011cited by this paper
• High phosphorus diet induces vascular calcification, a related decrease in bone mass and changes in the aortic gene expression.

  2010cited by this paper
• Continuous Elevation of PTH Increases the Number of Osteoblasts via Both Osteoclast-Dependent and -Independent Mechanisms

  2010cited by this paper
• The Associations of Fibroblast Growth Factor 23 and Uncarboxylated Matrix Gla Protein With Mortality in Coronary Artery Disease: The Heart and Soul Study

  2010cited by this paper
• Dietary Protein and Blood Pressure: A Systematic Review

  2010cited by this paper
• Impact of calcium, phosphate, PTH abnormalities and management on mortality in hemodialysis: results from the RISCAVID study.

  2010cited by this paper
• FoxO1 expression in osteoblasts regulates glucose homeostasis through regulation of osteocalcin in mice.

  2010cited by this paper
• Dietary Phosphorus, Blood Pressure, and Incidence of Hypertension in the Atherosclerosis Risk in Communities Study and the Multi-Ethnic Study of Atherosclerosis

  2010cited by this paper
• Fibroblast growth factor-23 (FGF-23) is independently correlated to aortic calcification in haemodialysis patients.

  2010cited by this paper
• Early control of PTH and FGF23 in normophosphatemic CKD patients: a new target in CKD-MBD therapy?

  2010cited by this paper
• Association of Calcium‐Phosphorus Product With Blood Pressure in Dialysis

  2010cited by this paper
• Circulating fibroblast growth factor-23 is associated with vascular dysfunction in the community.

  2009cited by this paper
• Pathogenesis of bone and mineral related disorders in chronic kidney disease: key role of hyperphosphatemia.

  2009cited by this paper
• Low bone volume--a risk factor for coronary calcifications in hemodialysis patients.

  2009cited by this paper
• Fibroblast Growth Factor 23 and Left Ventricular Hypertrophy in Chronic Kidney Disease

  2009cited by this paper
• Phosphorus and survival: key questions that need answers.

  2009cited by this paper
• Phosphonoformic Acid Prevents Vascular Smooth Muscle Cell Calcification by Inhibiting Calcium-Phosphate Deposition

  2009cited by this paper
• Phosphorus overload and PTH induce aortic expression of Runx2 in experimental uraemia.

  2009cited by this paper
• Elevated Serum Phosphate Predicts Mortality in Renal Transplant Recipients

  2009cited by this paper
• Hyperphosphatemia of chronic kidney disease.

  2008cited by this paper
• Progression of vascular calcifications is associated with greater bone loss and increased bone fractures

  2008cited by this paper
• Parathyroid hormone and the risk of incident hypertension

  2008cited by this paper
• Phosphate levels and blood pressure in incident hemodialysis patients: a longitudinal study.

  2008cited by this paper
• Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis.

  2008cited by this paper
• Dietary Phosphorus and Blood Pressure: International Study of Macro- and Micro-Nutrients and Blood Pressure

  2008cited by this paper
• Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS).

  2008cited by this paper
• Overexpression of Fibroblast Growth Factor 23 Suppresses Osteoblast Differentiation and Matrix Mineralization In Vitro

  2008cited by this paper
• Vascular calcifications, vertebral fractures and mortality in haemodialysis patients

  2008cited by this paper
• Oxidative Stress Induces Vascular Calcification through Modulation of the Osteogenic Transcription Factor Runx2 by AKT Signaling*

  2008cited by this paper
• Association of bone activity, calcium load, aortic stiffness, and calcifications in ESRD.

  2008cited by this paper
• Bone Turnover, Osteopenia and Vascular Calcifications in Hemodialysis Patients

  2008cited by this paper
• The relationship between dietary protein intake and blood pressure: results from the PREMIER study

  2008cited by this paper
• The mechanism of phosphorus as a cardiovascular risk factor in CKD.

  2008cited by this paper
• 1,25-Dihydroxyvitamin D3/VDR-mediated induction of FGF23 as well as transcriptional control of other bone anabolic and catabolic genes that orchestrate the regulation of phosphate and calcium mineral metabolism.

  2007cited by this paper
• Are PTH serum levels predictive of coronary calcifications in haemodialysis patients?

  2007cited by this paper
• Endocrine regulation of energy metabolism by the skeleton.

  2007cited by this paper
• Acute Effects of Different Phosphorus Sources on Calcium and Bone Metabolism in Young Women: A Whole-Foods Approach

  2007cited by this paper
• Role of hyperphosphatemia and 1,25-dihydroxyvitamin D in vascular calcification and mortality in fibroblastic growth factor 23 null mice.

  2007cited by this paper
• Phosphorus-containing food additives and the accuracy of nutrient databases: implications for renal patients.

  2007cited by this paper
• Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community.

  2007cited by this paper
• Aortic Msx2-Wnt Calcification Cascade Is Regulated by TNF-&agr;–Dependent Signals in Diabetic Ldlr−/− Mice

  2007cited by this paper
• Pyrophosphate, alkaline phosphatase, and vascular calcification.

  2006cited by this paper
• Vegetable protein and fiber from cereal are inversely associated with the risk of hypertension in a Spanish cohort.

  2006cited by this paper

• Association of dietary minerals and phosphorus to protein ratio with quality of life in Iranian Hemodialysis patients: a cross-sectional study

  2025cites this paper
• Focus on the Possible Role of Dietary Sodium, Potassium, Phosphate, Magnesium, and Calcium on CKD Progression

  2021cites this paper
• Pathophysiology of Vascular Calcification and Bone Loss: Linked Disorders of Ageing?

  2021cites this paper